1. A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study. Issue 1 (December 2016) Authors: Bridgewater, John; Lopes, Andre; Beare, Sandra; Duggan, Marian; Lee, Dymphna; Ricamara, Maravic; McEntee, Delyth; Sukumaran, Ajithkumar; Wasan, Harpreet; Valle, Juan Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study. Issue 1 (December 2016) Authors: Bridgewater, John; Lopes, Andre; Beare, Sandra; Duggan, Marian; Lee, Dymphna; Ricamara, Maravic; McEntee, Delyth; Sukumaran, Ajithkumar; Wasan, Harpreet; Valle, Juan Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase Ib Study of NUC‐1031 in Combination with Cisplatin for the First‐Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC‐08). (3rd December 2020) Authors: McNamara, Mairéad G.; Bridgewater, John; Palmer, Daniel H.; Faluyi, Olusola; Wasan, Harpreet; Patel, Alkesh; Ryder, William D.; Barber, Safia; Gnanaranjan, Chathunissa; Ghazaly, Essam; Evans, T.R. Jeff; Valle, Juan W. Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: e669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials. (11th May 2019) Authors: Lamarca, Angela; Ross, Paul; Wasan, Harpreet S; Hubner, Richard A; McNamara, Mairéad G; Lopes, Andre; Manoharan, Prakash; Palmer, Daniel; Bridgewater, John; Valle, Juan W Journal: Journal of the National Cancer Institute Issue: Volume 112:Number 2(2020) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial. (November 2019) Authors: Joharatnam-Hogan, Nalinie; Cafferty, Fay; Hubner, Richard; Swinson, Daniel; Sothi, Sharmila; Gupta, Kamalnayan; Falk, Stephen; Patel, Kinnari; Warner, Nicola; Kunene, Victoria; Rowley, Sam; Khabra, Komel; Underwood, Tim; Jankowski, Janusz; Bridgewater, John; Crossley, Anne; Henson, Verity; Berkma... Journal: Lancet gastroenterology and hepatology Issue: Volume 4:Number 11(2019) Page Start: 854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Issue 5 (May 2019) Authors: Primrose, John N; Fox, Richard P; Palmer, Daniel H; Malik, Hassan Z; Prasad, Raj; Mirza, Darius; Anthony, Alan; Corrie, Pippa; Falk, Stephen; Finch-Jones, Meg; Wasan, Harpreet; Ross, Paul; Wall, Lucy; Wadsley, Jonathan; Evans, Jeff T R; Stocken, Deborah; Praseedom, Raaj; Ma, Yuk Ting; Davidson, B... Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cholangiocarcinoma miscoding in hepatobiliary centres. (March 2021) Authors: Selvadurai, Shaun; Mann, Kulbir; Mithra, Sanjena; Bridgewater, John; Malik, Hassan; Khan, Shahid A. Journal: European journal of surgical oncology Issue: Volume 47:Supplement Part B (2021) Page Start: 635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal disease. Issue 13 (September 2015) Authors: Lamarca, Angela; Benafif, Sarah; Ross, Paul; Bridgewater, John; Valle, Juan W. Journal: European journal of cancer Issue: Volume 51:Issue 13(2015:Sep.) Page Start: 1694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Issue 8 (17th May 2022) Authors: Macias, Rocio I R; Cardinale, Vincenzo; Kendall, Timothy J; Avila, Matias A; Guido, Maria; Coulouarn, Cedric; Braconi, Chiara; Frampton, Adam E; Bridgewater, John; Overi, Diletta; Pereira, Stephen P; Rengo, Marco; Kather, Jakob N; Lamarca, Angela; Pedica, Federica; Forner, Alejandro; Valle, Juan ... Journal: Gut Issue: Volume 71:Issue 8(2022) Page Start: 1669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study. (October 2020) Authors: Crolley, Valerie E.; Hanna, Daire; Joharatnam-Hogan, Nalinie; Chopra, Neha; Bamac, Ekin; Desai, Meera; Lam, Yuk-Chun; Dipro, Sabiq; Kanani, Ruhi; Benson, Jack; Wilson, William; Fox, Thomas A.; Shiu, Kai-Keen; Forster, Martin; Bridgewater, John; Hochhauser, Daniel; Khan, Khurum Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗